News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
536,841 Results
Type
Article (39229)
Company Profile (84)
Press Release (497528)
Section
Business (152193)
Career Advice (2429)
Deals (27865)
Drug Delivery (87)
Drug Development (72612)
Employer Resources (142)
FDA (13530)
Job Trends (12181)
News (271506)
Policy (27026)
Tag
Academia (2519)
Alliances (38166)
Alzheimer's disease (1252)
Approvals (13460)
Artificial intelligence (120)
Bankruptcy (303)
Best Places to Work (9885)
Breast cancer (116)
Cancer (1028)
Cardiovascular disease (102)
Career advice (2040)
Cell therapy (218)
Clinical research (57780)
Collaboration (336)
Compensation (111)
COVID-19 (2409)
C-suite (103)
Data (1085)
Diabetes (141)
Diagnostics (5543)
Earnings (53929)
Employer resources (130)
Events (74338)
Executive appointments (303)
FDA (14028)
Funding (318)
Gene therapy (175)
GLP-1 (564)
Government (4051)
Healthcare (16023)
Infectious disease (2495)
Inflammatory bowel disease (99)
Interviews (522)
IPO (12526)
Job creations (2600)
Job search strategy (1677)
Layoffs (367)
Legal (5732)
Lung cancer (174)
Manufacturing (148)
Medical device (10540)
Medtech (10544)
Mergers & acquisitions (15406)
Metabolic disorders (388)
Neuroscience (1533)
NextGen Class of 2024 (5512)
Non-profit (3979)
Northern California (1280)
Obesity (215)
Opinion (188)
Parkinson's disease (75)
Patents (101)
People (49750)
Phase I (17712)
Phase II (25416)
Phase III (19436)
Pipeline (446)
Postmarket research (2306)
Preclinical (7260)
Radiopharmaceuticals (205)
Rare diseases (206)
Real estate (4105)
Regulatory (18459)
Research institute (2105)
Resumes & cover letters (357)
Southern California (1143)
Startups (2731)
United States (11131)
Vaccines (501)
Weight loss (167)
Date
Today (70)
Last 7 days (601)
Last 30 days (3232)
Last 365 days (31090)
2024 (28513)
2023 (34519)
2022 (45064)
2021 (48411)
2020 (46749)
2019 (39827)
2018 (30160)
2017 (27061)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (721)
Arizona (110)
Asia (33436)
Australia (6923)
California (2825)
Canada (1147)
China (221)
Colorado (121)
Connecticut (114)
Europe (73802)
Florida (414)
Georgia (92)
Illinois (285)
Indiana (175)
Kansas (81)
Maryland (514)
Massachusetts (1993)
Michigan (143)
Minnesota (204)
New Jersey (820)
New York (826)
North Carolina (576)
Northern California (1280)
Ohio (114)
Pennsylvania (671)
South America (991)
Southern California (1143)
Texas (391)
Utah (86)
Washington State (306)
536,841 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Press Releases
Greenwich LifeSciences Provides Update on Corporate Events
November 18, 2024
·
5 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Business
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
Chromocell Therapeutics Corp. today announced that it has formally launched its eye pain treatment program with the hiring of Dr. Simon Chandler.
March 21, 2024
·
5 min read
Deals
Edwards Lifesciences to Sell Critical Care to BD
Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD, in an all-cash transaction valued at $4.2 billion.
June 3, 2024
·
5 min read
Lone Star Bio
Greenwich LifeSciences Set to Join Russell 2000 Index Again
Greenwich LifeSciences, Inc. announced that it is set to join the Russell 2000 and Russell 3000 Indexes at the conclusion of the Russell indexes annual reconstitution, effective after the US markets open on July 1, 2024, according to a list of additions updated as of June 21, 2024.
June 26, 2024
·
5 min read
Business
Edwards Lifesciences Reports First Quarter 2024 Results
Edwards Lifesciences reported financial results for the quarter ended March 31, 2024.
April 25, 2024
·
20 min read
Press Releases
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
November 8, 2024
·
24 min read
Press Releases
New SELECT trial analysis with semaglutide 2.4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight
November 4, 2024
·
6 min read
Lone Star Bio
Greenwich LifeSciences Announces $2.5 Million Private Placement
Greenwich LifeSciences, Inc. announced that it has entered into a securities purchase agreement with its Chief Executive Officer, Snehal Patel, for the purchase and sale of 174,825 shares of its common stock at a purchase price of $14.30 per share in a private placement.
June 14, 2024
·
4 min read
1 of 53,685
Next
